A detailed history of Bessemer Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 160 shares of AMRX stock, worth $1,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160
Holding current value
$1,320
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.42 - $8.83 $1,027 - $1,412
160 New
160 $1,000
Q2 2019

Jul 19, 2019

SELL
$6.44 - $14.29 $16,100 - $35,725
-2,500 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$13.09 - $21.49 $32,725 - $53,724
2,500 New
2,500 $34,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.25B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.